Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Calcified Tissue International
Published in: Calcified Tissue International 1/2020

01-01-2020 | Sarcopenia | Review

Vitamin D and Skeletal Muscle: Emerging Roles in Development, Anabolism and Repair

Author: Christian M. Girgis

Published in: Calcified Tissue International | Issue 1/2020

Login to get access

Abstract

This special issue article will focus on morphologic and functional roles of vitamin D in muscle, from strength to contraction to development and ageing and will characterise the controversy of VDR’s expression in skeletal muscle, central to our understanding of vitamin D’s effects on this tissue.
Literature
1.
Floyd M, Ayyar DR, Barwick DD, Hudgson P, Weightman D (1974) Myopathy in chronic renal failure. Q J Med 43(172):509–524PubMed
2.
Girgis CM, Clifton-Bligh RJ, Hamrick MW, Holick MF, Gunton JE (2013) The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev 34(1):33–83PubMed
3.
Whistler D (1645) De morbo puerili Anglorum quem patrio idiomate indigenae vocant. The Rickets. Londini, London
4.
Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96(1):53–58PubMed
5.
Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF et al (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29(6):726–776PubMedPubMedCentral
6.
Cui X, Pelekanos M, Liu PY, Burne TH, McGrath JJ, Eyles DW (2013) The vitamin D receptor in dopamine neurons; its presence in human substantia nigra and its ontogenesis in rat midbrain. Neuroscience 236:77–87PubMed
7.
Brumbaugh PF, Haussler MR (1974) 1 Alpha,25-dihydroxycholecalciferol receptors in intestine. I. Association of 1 alpha,25-dihydroxycholecalciferol with intestinal mucosa chromatin. J Biol Chem 249(4):1251–1257PubMed
8.
Girgis CM (2018) Vitamin D and skeletal muscle. In: Feldman DJPW, Bouillon R, Giovanucci E, Goltzman D, Hewison M (eds) Vitamin D. Elsevier, Atlanta, pp 597–613
9.
Wang Y, Becklund BR, DeLuca HF (2010) Identification of a highly specific and versatile vitamin D receptor antibody. Arch Biochem Biophys 494(2):166–177PubMed
10.
Simpson RU, Thomas GA, Arnold AJ (1985) Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem 260(15):8882–8891PubMed
11.
Costa EM, Blau HM, Feldman D (1986) 1,25-Dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology 119(5):2214–2220PubMed
12.
Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T et al (2003) Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144(12):5138–5144PubMed
13.
Ceglia L, da Silva Morais M, Park LK, Morris E, Harris SS, Bischoff-Ferrari HA et al (2010) Multi-step immunofluorescent analysis of vitamin D receptor loci and myosin heavy chain isoforms in human skeletal muscle. J Mol Histol 41(2–3):137–142PubMedPubMedCentral
14.
Girgis CM, Mokbel N, Minn Cha K, Houweling PJ, Abboud M, Fraser DR et al (2014) The vitamin D receptor (VDR) is expressed in skeletal muscle of male mice and modulates 25-hydroxyvitamin D (25OHD) uptake in myofibers. Endocrinology 155(9):3227–3237PubMedPubMedCentral
15.
Bischoff HA, Borchers M, Gudat F, Duermueller U, Theiler R, Stahelin HB et al (2001) In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J. 33(1):19–24PubMed
16.
Buitrago C, Boland R (2010) Caveolae and caveolin-1 are implicated in 1alpha,25(OH)2-vitamin D3-dependent modulation of Src, MAPK cascades and VDR localization in skeletal muscle cells. J Steroid Biochem Mol Biol 121(1–2):169–175PubMed
17.
Wang Y, DeLuca HF (2011) Is the vitamin d receptor found in muscle? Endocrinology 152(2):354–363PubMed
18.
Olsson K, Saini A, Stromberg A, Alam S, Lilja M, Rullman E et al (2016) Evidence for vitamin D receptor expression and direct effects of 1 alpha, 25(OH)2D3 in human skeletal muscle precursor cells. Endocrinology 157(1):98–111PubMed
19.
Ceglia L, Niramitmahapanya S, Morais MD, Rivas DA, Harris SS, Bischoff-Ferrari H et al (2013) A randomized study on the effect of vitamin D3 supplementation on skeletal muscle morphology and vitamin D receptor concentration in older women. J Clin Endocrinol Metab 98(12):1927–1935
20.
Pojednic RM, Ceglia L, Olsson K, Gustafsson T, Lichtenstein AH, Dawson-Hughes B et al (2015) Effects of 1,25-dihydroxyvitamin D3 and vitamin D3 on the expression of the vitamin d receptor in human skeletal muscle cells. Calcif Tissue Int 96(3):256–263PubMed
21.
Lee SM, Bishop KA, Goellner JJ, O’Brien CA, Pike JW (2014) Mouse and human BAC transgenes recapitulate tissue-specific expression of the vitamin D receptor in mice and rescue the VDR-null phenotype. Endocrinology 155(6):2064–2076PubMedPubMedCentral
22.
Capiati D, Benassati S, Boland RL (2002) 1,25(OH)2-Vitamin D3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells. J Cell Biochem 86(1):128–135PubMed
23.
Buitrago C, de Boland R, Boland AR (2001) The tyrosine kinase c-Src is required for 1,25(OH)2-vitamin D3 signalling to the nucleus in muscle cells. Biochimica et Biophysica Acta. 1541(3):179–187PubMed
24.
Garcia LA, King KK, Ferrini MG, Norris KC, Artaza JN (2011) 1,25(OH)2vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology 152(8):2976–2986PubMedPubMedCentral
25.
Makanae Y, Ogasawara R, Sato K, Takamura Y, Matsutani K, Kido K et al (2015) Acute bout of resistance exercise increases vitamin D receptor protein expression in rat skeletal muscle. Exp Physiol 100(10):1168–1176PubMed
26.
Srikuea R, Zhang X, Park-Sarge OK, Esser KA (2012) VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation. Am J Physiol Cell Physiol 303(4):C396–C405PubMedPubMedCentral
27.
Cheng C, Alexander R, Min R, Leng J, Yip KY, Rozowsky J et al (2012) Understanding transcriptional regulation by integrative analysis of transcription factor binding data. Genome Res 22(9):1658–1667PubMedPubMedCentral
28.
29.
Johnson JA, Grande JP, Roche PC, Kumar R (1996) Ontogeny of the 1,25-dihydroxyvitamin D3 receptor in fetal rat bone. J Bone Miner Res 11(1):56–61PubMed
30.
Artaza JN, Norris KC (2009) Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol 200(2):207–221PubMed
31.
Garcia LA, Ferrini MG, Norris KC, Artaza JN (2013) 1,25(OH)(2)Vitamin D(3) enhances myogenic differentiation by modulating the expression of key angiogenic growth factors and angiogenic inhibitors in C(2)C(12) skeletal muscle cells. J Steroid Biochem Mol Biol 133:1–11PubMed
32.
Girgis CM, Clifton-Bligh RJ, Mokbel N, Cheng K, Gunton JE (2014) Vitamin D signaling regulates proliferation, differentiation, and myotube size in C2C12 skeletal muscle cells. Endocrinology 155(2):347–357PubMed
33.
Morelli S, Buitrago C, Boland R, de Boland AR (2001) The stimulation of MAP kinase by 1,25(OH)(2)-vitamin D(3) in skeletal muscle cells is mediated by protein kinase C and calcium. Mol Cell Endocrinol 173(1–2):41–52PubMed
34.
Buitrago CG, Pardo VG, de Boland AR, Boland R (2003) Activation of RAF-1 through Ras and protein kinase Calpha mediates 1alpha,25(OH)2-vitamin D3 regulation of the mitogen-activated protein kinase pathway in muscle cells. J Biol Chem 278(4):2199–2205PubMed
35.
Ronda AC, Buitrago C, Colicheo A, de Boland AR, Roldan E, Boland R (2007) Activation of MAPKs by 1alpha,25(OH)2-Vitamin D3 and 17beta-estradiol in skeletal muscle cells leads to phosphorylation of Elk-1 and CREB transcription factors. J Steroid Biochem Mol Biol 103(3–5):462–466PubMed
36.
Boland R, De Boland AR, Buitrago C, Morelli S, Santillan G, Vazquez G et al (2002) Non-genomic stimulation of tyrosine phosphorylation cascades by 1,25(OH)(2)D(3) by VDR-dependent and independent mechanisms in muscle cells. Steroids 67(6):477–482PubMed
37.
Tanaka M, Kishimoto KN, Okuno H, Saito H, Itoi E (2014) Vitamin D receptor gene silencing effects on differentiation of myogenic cell lines. Muscle Nerve 49(5):700–708PubMed
38.
Girgis CM, Cha KM, Houweling PJ, Rao R, Mokbel N, Lin M et al (2015) Vitamin D receptor ablation and vitamin D deficiency result in reduced grip strength, altered muscle fibers, and increased myostatin in mice. Calcif Tissue Int 97(6):602–610PubMed
39.
Seoane S, Alonso M, Segura C, Perez-Fernandez R (2002) Localization of a negative vitamin D response sequence in the human growth hormone gene. Biochem Biophys Res Commun 292(1):250–255PubMed
40.
Sakoda K, Fujiwara M, Arai S, Suzuki A, Nishikawa J, Imagawa M et al (1996) Isolation of a genomic DNA fragment having negative vitamin D response element. Biochem Biophys Res Commun 219(1):31–35PubMed
41.
Chen S, Villalta SA, Agrawal DK (2016) FOXO1 mediates vitamin D deficiency-induced insulin resistance in skeletal muscle. J Bone Miner Res 31(3):585–595PubMed
42.
Krishnaveni GV, Veena SR, Winder NR, Hill JC, Noonan K, Boucher BJ et al (2011) Maternal vitamin D status during pregnancy and body composition and cardiovascular risk markers in Indian children: the Mysore Parthenon Study. Am J Clin Nutr 93(3):628–635PubMed
43.
Harvey NC, Moon RJ, Sayer AA, Ntani G, Davies JH, Javaid MK et al (2014) Maternal antenatal vitamin D status and offspring muscle development: findings from the Southampton Women’s Survey. J Clin Endocrinol Metab 99(1):330–337PubMed
44.
Max D, Brandsch C, Schumann S, Kuhne H, Frommhagen M, Schutkowski A et al (2013) Maternal vitamin D deficiency causes smaller muscle fibers and altered transcript levels of genes involved in protein degradation, myogenesis, and cytoskeleton organization in the newborn rat. Mol Nutr Food Res 58:343–352PubMed
45.
Oku Y, Tanabe R, Nakaoka K, Yamada A, Noda S, Hoshino A et al (2016) Influences of dietary vitamin D restriction on bone strength, body composition and muscle in rats fed a high-fat diet: involvement of mRNA expression of MyoD in skeletal muscle. J Nutr Biochem 32:85–90PubMed
46.
Zhou H, Chen Y, Lv G, Zhuo Y, Lin Y, Feng B et al (2016) Improving maternal vitamin D status promotes prenatal and postnatal skeletal muscle development of pig offspring. Nutrition 32(10):1144–1152PubMed
47.
Alami-Durante H, Cluzeaud M, Bazin D, Mazurais D, Zambonino-Infante JL (2011) Dietary cholecalciferol regulates the recruitment and growth of skeletal muscle fibers and the expressions of myogenic regulatory factors and the myosin heavy chain in European sea bass larvae. J Nutr 141(12):2146–2151PubMed
48.
Harvey NC, Sheppard A, Godfrey KM, McLean C, Garratt E, Ntani G et al (2014) Childhood bone mineral content is associated with methylation status of the RXRA promoter at birth. J Bone Miner Res 29(3):600–607PubMed
49.
Girgis CM, Clifton-Bligh RJ, Turner N, Lau SL, Gunton JE (2014) Effects of vitamin D in skeletal muscle: falls, strength, athletic performance and insulin sensitivity. Clin Endocrinol (Oxf). 80(2):169–181PubMed
50.
Burne TH, Johnston AN, McGrath JJ, Mackay-Sim A (2006) Swimming behaviour and post-swimming activity in Vitamin D receptor knockout mice. Brain Res Bull 69(1):74–78PubMed
51.
Minasyan A, Keisala T, Zou J, Zhang Y, Toppila E, Syvala H et al (2009) Vestibular dysfunction in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol 114(3–5):161–166PubMed
52.
Schubert L, DeLuca HF (2010) Hypophosphatemia is responsible for skeletal muscle weakness of vitamin D deficiency. Arch Biochem Biophys 500(2):157–161PubMed
53.
Rodman JS, Baker T (1978) Changes in the kinetics of muscle contraction in vitamin D-depleted rats. Kidney Int 13(3):189–193PubMed
54.
Pleasure D, Wyszynski B, Sumner A, Schotland D, Feldman B, Nugent N et al (1979) Skeletal muscle calcium metabolism and contractile force in vitamin D-deficient chicks. J Clin Investig 64(5):1157–1167PubMedPubMedCentral
55.
Pointon JJ, Francis MJ, Smith R (1979) Effect of vitamin D deficiency on sarcoplasmic reticulum function and troponin C concentration of rabbit skeletal muscle. Clin Sci (Lond). 57(3):257–263PubMed
56.
Stroder J, Arensmeyer E (1965) Actomyosin content of the skeletal muscles in experimental rickets. Klin Wochenschr 43(22):1201–1202PubMed
57.
de Boland AR, Albornoz LE, Boland R (1983) The effect of cholecalciferol in vivo on proteins and lipids of skeletal muscle from rachitic chicks. Calcif Tissue Int 35(6):798–805PubMed
58.
Curry OB, Basten JF, Francis MJ, Smith R (1974) Calcium uptake by sarcoplasmic reticulum of muscle from vitamin D-deficient rabbits. Nature 249(452):83–84PubMed
59.
Tague SE, Clarke GL, Winter MK, McCarson KE, Wright DE, Smith PG (2011) Vitamin D deficiency promotes skeletal muscle hypersensitivity and sensory hyperinnervation. J Neurosci 31(39):13728–13738PubMedPubMedCentral
60.
Sakai S, Suzuki M, Tashiro Y, Tanaka K, Takeda S, Aizawa K et al (2015) Vitamin D receptor signaling enhances locomotive ability in mice. J Bone Miner Res 30(1):128–136PubMed
61.
Abboud M, Puglisi DA, Davies BN, Rybchyn M, Whitehead NP, Brock KE et al (2013) Evidence for a specific uptake and retention mechanism for 25-hydroxyvitamin D (25OHD) in skeletal muscle cells. Endocrinology 154(9):3022–3030PubMed
62.
Vazquez G, Boland R, de Boland AR (1995) Modulation by 1,25(OH)2-vitamin D3 of the adenylyl cyclase/cyclic AMP pathway in rat and chick myoblasts. Biochim Biophys Acta 1269(1):91–97PubMed
63.
Capiati DA, Vazquez G, Boland RL (2001) Protein kinase C alpha modulates the Ca2+ influx phase of the Ca2+ response to 1alpha,25-dihydroxy-vitamin-D3 in skeletal muscle cells. Horm Metab Res 33(4):201–206PubMed
64.
Boland RL (2011) VDR activation of intracellular signaling pathways in skeletal muscle. Mol Cell Endocrinol 347(1–2):11–16PubMed
65.
Morelli S, de Boland AR, Boland RL (1993) Generation of inositol phosphates, diacylglycerol and calcium fluxes in myoblasts treated with 1,25-dihydroxyvitamin D3. Biochem J. 289(Pt 3):675–679PubMedPubMedCentral
66.
Berchtold MW, Brinkmeier H, Muntener M (2000) Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease. Physiol Rev 80(3):1215–1265PubMed
67.
Sohl E, van Schoor NM, de Jongh RT, Visser M, Deeg DJ, Lips P (2013) Vitamin d status is associated with functional limitations and functional decline in older individuals. J Clin Endocr Metab 98(9):E1483–E1490PubMed
68.
Bhat M, Kalam R, Qadri SS, Madabushi S, Ismail A (2013) Vitamin D deficiency induced muscle wasting occurs through the ubiquitin proteasome pathway and is partially corrected by calcium in male rats. Endocrinology 154(11):4018–4029PubMed
69.
Antinozzi C, Corinaldesi C, Giordano C, Pisano A, Cerbelli B, Migliaccio S et al (2017) Potential role for the VDR agonist elocalcitol in metabolic control: evidences in human skeletal muscle cells. J Steroid Biochem Mol Biol 167:169–181PubMed
70.
Montero-Odasso M, Duque G (2005) Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone. Mol Aspects Med 26(3):203–219PubMed
71.
Phelps M, Pettan-Brewer C, Ladiges W, Yablonka-Reuveni Z (2013) Decline in muscle strength and running endurance in klotho deficient C57BL/6 mice. Biogerontology 14(6):729–739PubMed
72.
Semba RD, Cappola AR, Sun K, Bandinelli S, Dalal M, Crasto C et al (2012) Relationship of low plasma klotho with poor grip strength in older community-dwelling adults: the InCHIANTI study. Eur J Appl Physiol 112(4):1215–1220PubMed
73.
Bhat M, Ismail A (2015) Vitamin D treatment protects against and reverses oxidative stress induced muscle proteolysis. J Steroid Biochem Mol Biol 152:171–179PubMed
74.
Sinha A, Hollingsworth KG, Ball S, Cheetham T (2013) Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J Clin Endocr Metab 98(3):E509–E513PubMed
75.
Al-Eisa ES, Alghadir AH, Gabr SA (2016) Correlation between vitamin D levels and muscle fatigue risk factors based on physical activity in healthy older adults. Clin Interv Aging 11:513–522PubMedPubMedCentral
76.
Ryan ZC, Craig TA, Folmes CD, Wang X, Lanza IR, Schaible NS et al (2016) 1alpha,25-Dihydroxyvitamin D3 regulates mitochondrial oxygen consumption and dynamics in human skeletal muscle cells. J Biol Chem 291(3):1514–1528PubMed
77.
Owens DJ, Sharples AP, Polydorou I, Alwan N, Donovan T, Tang J et al (2015) A systems-based investigation into vitamin D and skeletal muscle repair, regeneration, and hypertrophy. Am J Physiol Endocrinol Metab. 309(12):E1019–E1031PubMed
78.
Stratos I, Li Z, Herlyn P, Rotter R, Behrendt AK, Mittlmeier T et al (2013) Vitamin D increases cellular turnover and functionally restores the skeletal muscle after crush injury in rats. Am J Pathol 182(3):895–904PubMed
79.
Choi M, Park H, Cho S, Lee M (2013) Vitamin D3 supplementation modulates inflammatory responses from the muscle damage induced by high-intensity exercise in SD rats. Cytokine 63(1):27–35PubMed
80.
Ke CY, Yang FL, Wu WT, Chung CH, Lee RP, Yang WT et al (2016) Vitamin D3 reduces tissue damage and oxidative stress caused by exhaustive exercise. Int J Med Sci 13(2):147–153PubMedPubMedCentral
81.
Srikuea R, Hirunsai M (1985) Effects of intramuscular administration of 1alpha, 25(OH)2D3 during skeletal muscle regeneration on regenerative capacity, muscular fibrosis, and angiogenesis. J Appl Physiol 120(12):1381–1393
82.
Barker T, Henriksen VT, Martins TB, Hill HR, Kjeldsberg CR, Schneider ED et al (2013) Higher serum 25-hydroxyvitamin D concentrations associate with a faster recovery of skeletal muscle strength after muscular injury. Nutrients 5(4):1253–1275PubMedPubMedCentral
83.
Barker T, Martins TB, Hill HR, Kjeldsberg CR, Dixon BM, Schneider ED et al (2014) Vitamin D sufficiency associates with an increase in anti-inflammatory cytokines after intense exercise in humans. Cytokine 65(2):134–137PubMed
84.
Pojednic RM, Ceglia L, Lichtenstein AH, Dawson-Hughes B, Fielding RA (2015) Vitamin D receptor protein is associated with interleukin-6 in human skeletal muscle. Endocrine 49(2):512–520PubMed
85.
Barker T, Schneider ED, Dixon BM, Henriksen VT, Weaver LK (2013) Supplemental vitamin D enhances the recovery in peak isometric force shortly after intense exercise. Nutr Metab (Lond). 10(1):69PubMedPubMedCentral
86.
Buitrago C, Vazquez G, De Boland AR, Boland RL (2000) Activation of Src kinase in skeletal muscle cells by 1, 1,25-(OH(2))-vitamin D(3) correlates with tyrosine phosphorylation of the vitamin D receptor (VDR) and VDR-Src interaction. J Cell Biochem 79(2):274–281PubMed
87.
Sandgren ME, Bronnegard M, DeLuca HF (1991) Tissue distribution of the 1,25-dihydroxyvitamin D3 receptor in the male rat. Biochem Biophys Res Commun 181(2):611–616PubMed
88.
Metadata
Title
Vitamin D and Skeletal Muscle: Emerging Roles in Development, Anabolism and Repair
Author
Christian M. Girgis
Publication date
01-01-2020
Publisher
Springer US
Keyword
Sarcopenia
Published in
Calcified Tissue International / Issue 1/2020
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-019-00583-4

Other articles of this Issue 1/2020

Calcified Tissue International 1/2020 Go to the issue

Editorial

Vitamin D in Musculoskeletal Health and Beyond

Review

Vitamin D, Autoimmune Disease and Rheumatoid Arthritis

Review

Targeting Vitamin D Deficiency to Limit Exacerbations in Respiratory Diseases: Utopia or Strategy With Potential?

Review

Vitamin D Measurement, the Debates Continue, New Analytes Have Emerged, Developments Have Variable Outcomes

Review

Vitamin D, and Maternal and Child Health

Review

The Latest Evidence from Vitamin D Intervention Trials for Skeletal and Non-skeletal Outcomes
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits